Skip to content

Consequences of the corona restrictions for cancer therapy and survivorship (CroKuS) (COVID-19)

Consequences of the corona restrictions for cancer therapy and survivorship (CroKuS) (COVID-19) - CroKuS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025155
Enrollment
2400
Registered
2021-08-31
Start date
2021-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C33 C34 C50 C18 C19 C20 C61 C81-C96 F32

Interventions

Group 1: Non-interventional observational study. Participants are asked to complete a questionnaire once in time. Later, registry data will be linked for those participants who give their consent.

Sponsors

Deutsches Krebsforschungszentrum (DKFZ)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ­- Living in Baden-Württemberg ­- Men and women with 1 of the following primary cancers: Lung cancer [C33-C34], prostate cancer [C61], breast cancer [C50], colorectal cancer [C18-C20], hematooncological disease [C81-C96] - Age at recruitment 18-85 years - Diagnosis: 07/2015-06/2020, 1/3 of those with diagnosis 07/2015-06/2019 and 2/3 with diagnosis 07/2019-06/2020 - Not reported to the cancer registry as diseased until 31/12/2020 - Able to give informed consent

Exclusion criteria

Exclusion criteria: ­Disagreement to recording of identity data in the cancer registry of Baden-Württemberg, general disagreement to participate in studies, deceased before receiving the study questionnaire, malign secondary cancer [C00-C97 except C44]

Design outcomes

Primary

MeasureTime frame
Changes in oncological care

Secondary

MeasureTime frame
Health-related quality of life, stress, depressive symptoms, financial situation

Countries

Germany

Contacts

Public ContactVolker Arndt

Deutsches Krebsforschungszentrum, Cancer Survivorship (C071)

v.arndt@dkfz.de06221 42-2401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026